Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Representatives from the University of Oxford and the Tak Provincial Public Health Office signed a Memorandum of Understanding (MoU) to strengthen collaboration on infectious disease prevention and control along the Thai–Myanmar border. The agreement focuses on joint research into key diseases affecting the border population.

Professor François Nosten, SMRU Director; Dr Pitakpong Chandang, Tak Provincial Chief Medical Officer; Dr Sutha Phatrakitrungruang, Mae Ramat Hospital Director

Professor François Nosten, Director of the Shoklo Malaria Research Unit (SMRU); Dr Pitakpong Chandang, Tak Provincial Chief Medical Officer; and Dr Sutha Phatrakitrungruang, Director of Mae Ramat Hospital, signed a MoU on co-operation for the development of infectious disease prevention and control along the Tak border area. The signing ceremony took place in the meeting room of the Primary Care Unit building in Mae Ramat District, Tak Province.

The University of Oxford and the Tak Provincial Public Health Office intend to develop a collaboration for the prevention and control of infectious diseases in the border area of Tak Province. This work will take place under the MoU between Mae Ramat Hospital and SMRU, a unit operated by the University of Oxford.

The collaboration will focus on the epidemiology, clinical presentation, and laboratory investigations of infectious diseases. It will be jointly conducted by Mae Ramat Hospital and SMRU. The aim is to improve the control of major infectious diseases affecting the border population, including (but not limited to) tuberculosis, respiratory pathogens, HIV, malaria, hepatitis B, melioidosis, rickettsiosis, dengue, intestinal parasites, and emerging infectious diseases.

This initiative will include studies on epidemiology, diagnostics, treatment and prevention strategies, and will align with the objectives of the Mahidol–Oxford Tropical Health Network.

Similar stories

Salum Mshamu named a 2026 TIME Trailblazer

Congratulations to Salum Mshamu on being selected as one of TIME’s inaugural 2026 Trailblazers: Designing and Making the Future. A University of Oxford DPhil student, Salum was recognised for his contribution to research showing how improved housing design can reduce malaria and other childhood illnesses.

University of Oxford announces next-generation Ai initiative to detect, assess and respond to pandemics

The University of Oxford has been awarded €8 million through the European Union’s Horizon Europe programme to coordinate the development of the Pandemics AI Observatory (PANDAI).

Inaugural Sir John Bell Lecture Celebrates a Legacy of Innovation and the Future of Human Health

Creating a map of every cell in the human body is one of the most ambitious goals in modern science. Through the Human Cell Atlas, an international collaboration involving thousands of researchers worldwide, scientists are building a reference map of human cells that is reshaping understanding of health and disease.

Team ATLAS sets out strategy to investigate cancer avoidance as part of Cancer Grand Challenges

A new position paper from team ATLAS sets out plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit

The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.

UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.